Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives

Juan P. Arab, Marco Arrese, Vijay H. Shah

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

The term, gut–liver axis, is used to highlight the close anatomical and functional relationship between the intestine and the liver. It has been increasingly recognized that the gut–liver axis plays an essential role in the development and progression of liver disease. In particular, in non-alcoholic fatty liver disease and alcohol-related liver disease, the two most common causes of chronic liver disease, a dysbiotic gut microbiota can influence intestinal permeability, allowing some pathogens or bacteria-derived factors from the gut reaching the liver through the enterohepatic circulation contributing to liver injury, steatohepatitis, and fibrosis progression. Pathways involved are multiple, including changes in bile acid metabolism, intestinal ethanol production, generation of short-chain fatty acids, and other by-products. Bile acids act through dedicated bile acid receptors, farnesoid X receptor and TGR5, in both the ileum and the liver, influencing lipid metabolism, inflammation, and fibrogenesis. Currently, both non-alcoholic fatty liver disease and alcohol-related liver disease lack effective therapies, and therapeutic targeting of gut microbiota and bile acids enterohepatic circulation holds promise. In this review, we summarize current knowledge about the role of gut microbiota in the pathogenesis of non-alcoholic fatty liver disease and alcohol-related liver disease, as well as the relevance of microbiota or bile acid-based approaches in the management of those liver diseases.

Original languageEnglish (US)
Pages (from-to)407-418
Number of pages12
JournalHepatology Research
Volume50
Issue number4
DOIs
StatePublished - Apr 1 2020

Keywords

  • alcohol
  • alcohol-related liver disease
  • bile acids
  • cirrhosis
  • fatty liver
  • gut–liver axis
  • microbiota
  • non-alcoholic fatty liver disease
  • steatosis
  • translocation

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives'. Together they form a unique fingerprint.

Cite this